Wellstar International, Inc., through its subsidiary, Trillennium Medical Imaging, Inc., engages in developing and licensing the use of advanced thermal imaging technology in the consumer health care markets in the United States. The company places cameras for a monthly charge in hospitals, and clinical and long care facilities throughout the United States. The TMI Infrared Technology and software is approved by the FDA as an adjunctive diagnostic screening procedure for early breast cancer detection, differential diagnosis of pain dysfunctions, detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Markets The company serves major markets, such as university research centers, hospitals, multidisciplinary physician practices, pain centers, long term care facilities, home health care, and rehabilitation centers. History Wellstar International, Inc. was founded in 1997.
wellstar international inc
6911 Pilliod Road
Holland, OH 43528
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for WLSI.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact WELLSTAR INTERNATIONAL INC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.